Amgen Evolocumab In Combination With Statin Therapy Reduces LDL Cholesterol
THOUSAND OAKS dpaAFX Amgen AMGN announced the publication of data from the Phase 3 LAPLACE2 LDLC Assessment with PCSK9 MonoclonaL Antibody Inhibition Combined with Statin ThErapy2 stud...
View ArticleEffect of Evolocumab or Ezetimibe Added to Moderate or HighIntensity Statin...
ImportanceIn phase 2 studies evolocumab a fully human monoclonal antibody to PCSK9 reduced LDLC levels in patients receiving statin therapy.ObjectiveTo evaluate the efficacy and tolerability of...
View ArticleEvolocumab combined with statin results in further reduction of cholesterol...
Among patients with high cholesterol receiving moderate or highintensity statin therapy the addition of the human monoclonal antibody evolocumab resulted in additional lowering of lowdensity...
View ArticleNew Drug May Help Lower 'Bad' Cholesterol Beyond Statins
TUESDAY May 13 2014 A new injectable drug can further knock down cholesterol levels in people who take cholesterolbusting statin medications according to the results of a global trial.People taking the...
View ArticleAmgens Monoclonal Antibody Slashes LDLC
Amgen announced the publication of data from the Phase 3 LAPLACE2 LDLC Assessment with PCSK9 MonoclonaL Antibody Inhibition Combined with Statin ThErapy2 study in the Journal of the American Medical Asso
View ArticleAmgens Monoclonal Ab Slashes LDLC
Amgen announced the publication of data from the Phase 3 LAPLACE2 LDLC Assessment with PCSK9 MonoclonaL Antibody Inhibition Combined with Statin ThErapy2 study in the Journal of the American Medical Asso
View ArticleStatin Risks Misstated in Journal Articles
MedPage Today Statements placing the adverse event rate associated with statin use at 18 to 20 have been withdrawn from two papers published in BMJ last year.
View ArticleEvolocumab helps lower cholesterol in statintreated patients
Addition of evolocumab to moderate or highintensity statin therapy is well tolerated and leads to further reductions in lowdensity lipoprotein cholesterol LDLC a phase III clinical trial has shown....
View ArticleWhen Do Patients With Type 1 Diabetes Need Statins
What do guidelines say about statin use in patients with type 1 diabetes Medscape Pharmacists
View ArticleMuscle pain not well defined in most statin studies
NEW YORK Reuters Health Studies evaluating cholesterollowering drugs might find more muscle problems if they did a better job of defining and asking about muscle pain suggests a new review.
View ArticleBMJ Withdraws Statement on StatinRelated AEs
Two research papers erroneously cited that 20 of patients develop statinrelated adverse events a figure that is based on observational data. These statements have been withdrawn and BMJ will review...
View ArticleMisreading of Data Led to Errors in Statin Papers
Nature &8211; TheÂBMJ is modifying and is considering whether to retract articles that questioned whether many patients should be given cholesterollowering statin drugs. The articles made a...
View ArticleComment Are statins to be STASHed in subarachnoid haemorrhage
In The Lancet Neurology Peter Kirkpatrick and colleagues report the results of an important randomised trial of simvastatin treatment for aneurysmal subarachnoid hemorrhage SAH. Unfortunately...
View ArticleSerious muscle damage risk from widely used cholesterol lowering drug very...
Medical XpressPatients taking a higher dose of simvastatin one of the statin drugs used to prevent heart attacks and strokes have a greater risk of rhabdomyolysis than people taking a lower dose...
View ArticleBMJ retracts data on statin side effects
The BMJ has withdrawn statements in two papers published last year that suggested statin treatments resulted in side effects in 1820 of patients. An editorial by The BMJs editor in chief Fiona Godlee...
View ArticleTempleled study finds no benefit in taking statin drugs for COPD exacerbation...
A statin drug commonly used to lower cholesterol is not effective in reducing the number and severity of flare ups from chronic obstructive pulmonary disease COPD according to the results of a large...
View ArticleRegistration now open for interactive one day workshop for GPs
Registration is now open for an interactive one day workshop in Brisbane designed by GPs for GPs that will cover five hot topics including statin prescribing and whether the hype is justified on newer...
View ArticleFamilial Hypercholesterolemia Type II Hyperlipoproteinemia Global Clinical...
Recently added to the BioPortfolio report storeFamilial Hypercholesterolemia Type II Hyperlipoproteinemia Global Clinical Trials Review H1 2014 is a new report fromGlobalData published on 20140514.This...
View ArticleCardioBuzz Judges for Statin Papers Named
MedPage Today BMJ released on Monday the roster of an independent panel charged with deciding whether two papers containing inaccurate statements about the risks of statins should be retracted.
View ArticleSimvastatin has no therapeutic benefit in COPD researchers conclude
Simvastatin does not prevent exacerbations in people with moderatetosevere chronic obstructive pulmonary disease COPD suggest results of a large prospective randomised placebocontrolled trial reported...
View Article